Are surrogate markers adequate to assess cardiovascular disease drugs?

被引：218

作者：

Temple, R ^{[1
]}

机构：

[1] US FDA, Ctr Drug Evaluat & Res Policy, Rockville, MD 20857 USA

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1999年 / 282卷 / 08期

关键词：

D O I：

10.1001/jama.282.8.790

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：790 / 795

页数：8

共 30 条

[1] Alderman M, 1997, J HYPERTENS, V15, P105
[2] [Anonymous], 1992, Fed Regist, V57, P58942
[3] [Anonymous], 1970, JAMA-J AM MED ASSOC, V213, P1143, DOI DOI 10.1001/JAMA.213.7.1143
[4] What have we learned from the calcium channel blocker controversy?
Califf, RM
Kramer, JM
[J]. CIRCULATION, 1998, 97 (16) : 1529 - 1531
[5] A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure
Cohn, JN
Goldstein, SO
Greenberg, BH
Lorell, BH
Bourge, RC
Jaski, BE
Gottlieb, SO
McGrew, F
DeMets, DL
White, BG
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (25) : 1810 - 1816
[6] BLOOD-PRESSURE, STROKE, AND CORONARY HEART-DISEASE .2. SHORT-TERM REDUCTIONS IN BLOOD-PRESSURE - OVERVIEW OF RANDOMIZED DRUG TRIALS IN THEIR EPIDEMIOLOGIC CONTEXT
COLLINS, R
PETO, R
MACMAHON, S
HEBERT, P
FIEBACH, NH
EBERLEIN, KA
GODWIN, J
QIZILBASH, N
TAYLOR, JO
HENNEKENS, CH
[J]. LANCET, 1990, 335 (8693) : 827 - 838
[7] Rationale and design for the antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT)
Davis, BR
Cutler, JA
Gordon, DJ
Furberg, CD
Wright, JT
Cushman, WC
Grimm, RH
LaRosa, J
Whelton, PK
Perry, HM
Alderman, MH
Ford, CE
Oparil, S
Francis, C
Proschan, M
Pressel, S
Black, HR
Hawkins, CM
[J]. AMERICAN JOURNAL OF HYPERTENSION, 1996, 9 (04) : 342 - 360
[8] MORTALITY AND MORBIDITY IN PATIENTS RECEIVING ENCAINIDE, FLECAINIDE, OR PLACEBO - THE CARDIAC-ARRHYTHMIA SUPPRESSION TRIAL
ECHT, DS
LIEBSON, PR
MITCHELL, LB
PETERS, RW
OBIASMANNO, D
BARKER, AH
ARENSBERG, D
BAKER, A
FRIEDMAN, L
GREENE, HL
HUTHER, ML
RICHARDSON, DW
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (12) : 781 - 788
[9] Surrogate end points in clinical trials: Are we being misled?
Fleming, TR
DeMets, DL
[J]. ANNALS OF INTERNAL MEDICINE, 1996, 125 (07) : 605 - 613
[10] A cardiologist's perspective on evolving concepts in the management of congestive heart failure
Forker, AD
[J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 36 (11): : 973 - 984

← 1 2 3 →